Deepa Raghavan1, Anita Varkey, Thaddeus Bartter. 1. aDivision of Pulmonary and Critical Care, University of Arkansas for Medical Sciences bCentral Arkansas Veterans Healthcare System, Little Rock, Arkansas cDivision of Primary Care, Loyola University Medical Center, Stritch School of Medicine, Maywood, Illinois, USA.
Abstract
PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) is a widely prevalent and potentially preventable cause of death worldwide. The purpose of this review is to summarize the influence of gender on various attributes of this disease, which will help physicians provide more personalized care to COPD patients. RECENT FINDINGS: Cultural trends in smoking have morphed the epidemiology of this traditionally male disease. There is an increasing 'disease burden' among women with COPD as suggested by the higher prevalence and slower decline in death rates as compared with men. Biologic differences between the genders account for some, but not all of these differences. In women, distinct features need to be considered to boost success of therapeutic interventions such as smoking cessation, addressing comorbidities, and attendance to pulmonary rehabilitation. SUMMARY: COPD in women is distinct from that in men with respect to phenotype, symptom burden, and comorbidities. Women are more predisposed to develop chronic bronchitis, have more dyspnea, and suffer more frequently from coexistent anxiety or depression. They may be more subject than men to misdiagnoses and/or underdiagnoses of COPD, often as a result of physician bias. Knowledge of these gender differences can lead to more effective tailored care of the COPD patient.
PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) is a widely prevalent and potentially preventable cause of death worldwide. The purpose of this review is to summarize the influence of gender on various attributes of this disease, which will help physicians provide more personalized care to COPDpatients. RECENT FINDINGS: Cultural trends in smoking have morphed the epidemiology of this traditionally male disease. There is an increasing 'disease burden' among women with COPD as suggested by the higher prevalence and slower decline in death rates as compared with men. Biologic differences between the genders account for some, but not all of these differences. In women, distinct features need to be considered to boost success of therapeutic interventions such as smoking cessation, addressing comorbidities, and attendance to pulmonary rehabilitation. SUMMARY:COPD in women is distinct from that in men with respect to phenotype, symptom burden, and comorbidities. Women are more predisposed to develop chronic bronchitis, have more dyspnea, and suffer more frequently from coexistent anxiety or depression. They may be more subject than men to misdiagnoses and/or underdiagnoses of COPD, often as a result of physician bias. Knowledge of these gender differences can lead to more effective tailored care of the COPDpatient.
Authors: Joakim Åberg; Mikael Hasselgren; Scott Montgomery; Karin Lisspers; Björn Ställberg; Christer Janson; Josefin Sundh Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-05-07
Authors: Hanna Sandelowsky; Ingvar Krakau; Sonja Modin; Björn Ställberg; Anna Nager Journal: Scand J Prim Health Care Date: 2019-11-07 Impact factor: 2.581
Authors: Hamid Akbarshahi; Zainab Ahmadi; David C Currow; Jacob Sandberg; Zac Vandersman; Aaron Shanon-Honson; Magnus Ekström Journal: ERJ Open Res Date: 2020-11-10
Authors: Abdelilah Benslimane; Vanessa Garcia-Larsen; Khaoula El Kinany; Amina Alaoui Chrifi; Zineb Hatime; Mohamed Chakib Benjelloun; Mohammed El Biaze; Chakib Nejjari; Karima El Rhazi Journal: SAGE Open Med Date: 2021-07-17